ASU researchers have identified new methods and compositions to directly target therapeutics to tumors while also performing diagnostic imaging. Ultrasound contrast agent materials are combined with glycopeptide-based antibiotics in a unique formulation capable of simultaneous targeting of therapeutics and selective imaging. Traditionally used...